Israel’s bio institute chief says regulation slowing down vaccine development

The head of the Defense Ministry’s Institute for Biological Research gripes that regulation is slowing down testing on the COVID-19 vaccine that it’s developing.

Prof. Shmuel Shapira tells a Knesset committee that the institute finished stage trials five days ago and is set to begin stage 2 trials within the next 10 days.

“If we hadn’t encountered excess regulation, we would’ve progressed more. We were meant to be in the third stage already and now we’ll only reach it in April,” he’s quoted saying in a statement from the Knesset.

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.